This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PAP Conference 2023 – Patient Assistance & Access Programs
March 20-22, 2023
Delivered as a Hybrid EventPhiladelphia Marriott Downtown

2023 SUMMIT SCHOLARSHIP PROGRAM

The 2023 Patient Assistance and Access Programs convenes stakeholders in the healthcare community to discuss models for institutional PAPs, medication assistance, prescription access, drug affordability and copay support. 

Any questions about the scholarship program, please contact Allie Spica at alexandra.spica@informa.com.

Guidelines for PAP Scholarship Applications

Deadline: February 10, 2023

SCHOLARSHIP AWARD

Award: Complimentary registration for one (1) representative

SCHOLARSHIP GUIDELINES

Who can apply: All non-profit free healthcare clinics, advocacy groups and patient organizations are welcome to apply for a scholarship. Organizations must have 501(c)(3) tax-exempt status. Scholarships are limited to one (1) representative from each organization.

THE APPLICATION PROCESS

  • Each applicant must complete the entire application form
  • Applications must be submitted by the deadline, February 10, 2023

THE REVIEW AND DETERMINATION PROCESS

The PAP - Patient Assistance & Access Programs organizers will review all applications and will determine awards based on the following criteria:

  • Completeness of the application
  • Submission by deadline
  • Consideration of the organization’s mission within the patient assistance community

All applicants will be notified of their determination by February 13, 2023 and applicants must accept their award by February 17, 2023. Once an award is accepted you will automatically be registered for an all access pass, which includes access to the in-person and virtual programming. Does not include travel assistance.